Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6

Toxicology Letters

Volumn 206, Issue 1, 2011, Pages 72-76

  Seeger, T ^a   Niessen, K V ^a   Langer, P ^a   Gerhardus, J ^a   Worek, F ^a   Friess, H ^b   Bumm, R ^b   Mihaljevic, A L ^b   Thiermann, H ^a  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acetylcholinesterase; Human intercostal muscle; Nerve agent poisoning; Neuromuscular function; Oximes

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; SARIN; SOMAN; TABUN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; INTERCOSTAL MUSCLE; MUSCLE FORCE; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; AGED; CHEMICAL WARFARE AGENTS; CHOLINESTERASE REACTIVATORS; ELECTRIC STIMULATION; HUMANS; INTERCOSTAL MUSCLES; MUSCLE STRENGTH; NEUROMUSCULAR JUNCTION; OXIMES; PHOSPHORIC ACID ESTERS; PYRIDINIUM COMPOUNDS; SARIN; SOMAN;

EID: 80051804061     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.07.016     Document Type: Article

References (38)

1. Alberts P. A new H-oxime restores rat diaphragm contractility after esterase inhibition in vitro. Eur. J. Pharmacol. 1990, 184:191-194.
2. Buelbring E. Observations on the isolated phrenic nerve diaphragm preparation of the rat. Br. J. Pharmacol. 1946, 1:38-61.
3. Clement J.G., Rosario S., Bessette E., Erhardt N. Soman and sarin inhibition of molecular forms of acetylcholinesterase in mice - time course of recovery and reactivation by the oxime HI-6. Biochem. Pharmacol. 1991, 42:329-335.
4. de Silva H.J., Wijewickrema R., Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning?. Lancet 1992, 339:1136-1138.
5. Eckert S., Eyer P., Herkert N., Bumm R., Weber G., Thiermann H., Worek F. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity. Biochem. Pharmacol. 2008, 75:698-703.
6. Eyer F., Worek F., Eyer P., Felgenhauer N., Haberkorn M., Zilker T., Thiermann H. Obidoxime in acute organophosphate poisoning: 1 - Clinical effectiveness. Clin. Toxicol. (Phila) 2009, 47(8):798-806.
7. Eyer P. Optimal oxime dosage regimen, a pharmacokinetic approach. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning 1996, 33-51. Spektrum Akademischer Verlag, Heidelberg/Berlin/Oxford. L. Szinicz, P. Eyer, R. Klimmek (Eds.).
8. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol. Rev. 2003, 22:165-190.
9. Eyer P., Worek F. Oximes 2007, 305-329. John Wiley & Sons Ltd., Chichester. T.C. Marrs, R.L. Maynard, F.R. Sidell (Eds.).
10. Eyer P., Worek F., Thiermann H., Eddleston M. Paradox findings may challenge orthodox reasoning in acute organophosphate poisoning 230. Chem. Biol. Interact. 2010, 187(1-3):270-278.
11. Fernandez H.L., Inestrosa N.C., Stiles J.R. Subcellular localization of acetylcholinesterase molecular forms in endplate regions of adult mammalian skeletal muscle. Neurochem. Res. 1984, 9(9):1211-1230.
12. Herkert N.M., Aurbek N., Eyer P., Thiermann H., Worek F. Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon. Toxicol. Lett. 2010, 194:94-101.
13. Johnson C.D., Russell R.L. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 1975, 64:229-238.
14. Klimmek R., Eyer P. Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs. Arch. Toxicol. 1986, 59:272-278.
15. Lundy P.M., Raveh L., Amitai G. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol. Rev. 2006, 25(4):231-243.
16. Peter J.V., Moran J.L., Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit. Care Med. 2006, 34(2):502-510.
17. Potter L.T. A radiometric microassay of acetylcholinesterase. J. Pharmacol. Exp. Ther. 1967, 156(3):500-506.
18. Seeger T., Worek F., Szinicz L., Thiermann H. Reevaluation of indirect field stimulation technique to demonstrate oxime effectiveness in OP-poisoning in muscles in vitro. Toxicology 2007, 233(1-3):209-213.
19. Segal S.S., Faulkner J.A. Temperature-dependent physiological stability of rat skeletal muscle in vitro. Am. J. Physiol. 1985, 248:C265-C270.
20. Shafferman A., Ordentlich A., Barak D., Stein D., Ariel N., Velan B. Aging of phosphylated human acetylcholinesterase: Catalytic processes mediated by aromatic and polar residues of the active centre. Biochem. J. 1996, 318(Pt 3):833-840.
21. Sidell F. Nerve agents. Medical Aspects of Chemical and Biological Warfare, Textbook of Military Medicine 2007, 129-179. Office of The Surgeon General at TMM Publications, Washington, DC. Russ Zajtchuk, R.F. Bellamy (Eds.).
22. Sidell F.R., Groff W.A., Kaminskis A. Toxogonin and pralidoxime: kinetic comparison after intravenous administration to man. J. Pharm. Sci. 1972, 61(11):1765-1769.
23. Smith A.P., Van Der Wiel H.J., Wolthuis O.L. Analysis of oxime-induced neuromuscular recovery in guinea pig, rat and man following soman poisoning in vitro. Eur. J. Pharmacol. 1981, 70(3):371-379.
24. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150(1):76-85.
25. Spöhrer U., Thiermann H., Klimmek R., Eyer P. Pharmacokinetics of the oximes HI 6 and HLo 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors. Arch. Toxicol. 1994, 68:480-489.
26. Tattersall J.E. Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br. J. Pharmacol. 1993, 108(4):1006-1015.
27. Tattersall J.E., Smith A.P., Waters K., Mistry R., Weeden D. Therapeutic action of HI-6 against soman poisoning in vitro: an interspecies comparison. Br. J. Pharmacol. 1998, 125:7P.
28. Taugner R., Taugner M., Lohmueller T., Fleckenstein A. Etiology of muscular asthenia in adrenocortical insufficiency; investigations of the isolated diaphragm of normal and adrenalectomized rats subject to varying extracellular concentrations of sodium, potassium, calcium and glucose. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1950, 210(3):219-235.
29. Thiermann H., Eyer P., Worek F., Szinicz L. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon. Toxicology 2005, 214(3):190-197.
30. Thiermann H., Worek F., Eyer P., Eyer F., Felgenhauer N., Zilker T. Obidoxime in acute organophosphate poisoning: 2 - PK/PD relationships. Clin. Toxicol. (Phila) 2009, 47(8):807-813.
31. Thiermann H., Zilker T., Eyer F., Felgenhauer N., Eyer P., Worek F. Monitoring of neuromuscular transmission in organophosphate pesticide-poisoned patients. Toxicol. Lett. 2009, 191(2-3):297-304.
32. Van Helden H.P., Van Der Wiel H.J., de L.J., Busker R.W., Melchers B.P., Wolthuis O.L. Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys. Toxicol. Appl. Pharmacol. 1992, 115(1):50-56.
33. Wilson I.B., Ginsburg S. A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochem. Biophys. Acta 1955, 18:168-170.
34. Wolthuis O.L., Vanwersch R.A.P., Van Der Wiel H.J. The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man. Eur. J. Pharmacol. 1981, 70:355-369.
35. Worek F., Aurbek N., Thiermann H. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. J. Appl. Toxicol. 2007.
36. Worek F., Baecker M., Thiermann H., Szinicz L., Mast U., Klimmek R., Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum. Exp. Toxicol. 1997, 16:466-472.
37. Worek F., Thiermann H., Szinicz L. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines. Arch. Toxicol. 2004, 78(4):212-217.
38. Worek F., Thiermann H., Szinicz L., Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem. Pharmacol. 2004, 68(11):2237-2248.